What's happening.

FEATURED

Read the latest.

The Times Business commentary article, Featuring Antiverse

Exclusive: AI biotech Antiverse raises $9.3M Series A

Nxera Pharma and Antiverse Enter Collaboration To Design Novel GPCR-Targeted Antibody Therapeutics Using Generative AI

The Times Business commentary article, Featuring Antiverse

Exclusive: AI biotech Antiverse raises $9.3M Series A

Nxera Pharma and Antiverse Enter Collaboration To Design Novel GPCR-Targeted Antibody Therapeutics Using Generative AI

The Times Business commentary article, Featuring Antiverse

Exclusive: AI biotech Antiverse raises $9.3M Series A

Nxera Pharma and Antiverse Enter Collaboration To Design Novel GPCR-Targeted Antibody Therapeutics Using Generative AI

Better biologics for the toughest targets.

©2026 Antiverse. All rights reserved.

Better biologics for the toughest targets.

©2026 Antiverse. All rights reserved.

Better biologics for the toughest targets.

©2026 Antiverse. All rights reserved.